Translational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variants
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Translational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variants
Authors
Keywords
-
Journal
RNA Biology
Volume -, Issue -, Pages 1-10
Publisher
Informa UK Limited
Online
2019-10-15
DOI
10.1080/15476286.2019.1676115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aminoglycoside drugs induce efficient read-through of CDKL5 nonsense mutations, slightly restoring its kinase activity
- (2019) Maria Fazzari et al. RNA Biology
- Amlexanox provides a potential therapy for nonsense mutations in the lysosomal storage disorder Aspartylglucosaminuria
- (2018) Antje Banning et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Female Fabry disease patients and X-chromosome inactivation
- (2018) Patrycja Juchniewicz et al. GENE
- Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B
- (2018) Mattia Ferrarese et al. HUMAN MUTATION
- The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation
- (2018) S. Pignani et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Akt‐mediated phosphorylation of MICU1 regulates mitochondrial Ca2+ levels and tumor growth
- (2018) Saverio Marchi et al. EMBO JOURNAL
- Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells
- (2017) Laure Bidou et al. RNA Biology
- Fabry Disease: Recognition, Diagnosis, and Treatment of Neurological Features
- (2016) Michela Ranieri et al. Current Treatment Options in Neurology
- The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat
- (2016) Elfrida R. Benjamin et al. GENETICS IN MEDICINE
- HGVS Recommendations for the Description of Sequence Variants: 2016 Update
- (2016) Johan T. den Dunnen et al. HUMAN MUTATION
- Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency
- (2016) A. Branchini et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Aminoglycoside-stimulated readthrough of premature termination codons in selected genes involved in primary ciliary dyskinesia
- (2016) Zuzanna Bukowy-Bieryllo et al. RNA Biology
- Lysosomal Storage Diseases: From Pathophysiology to Therapy
- (2015) Giancarlo Parenti et al. Annual Review of Medicine
- The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X
- (2015) A. Branchini et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Effect of Readthrough Treatment in Fibroblasts of Patients Affected by Lysosomal Diseases Caused by Premature Termination Codons
- (2015) Leslie Matalonga et al. Neurotherapeutics
- Nonsense suppression by near-cognate tRNAs employs alternative base pairing at codon positions 1 and 3
- (2015) Bijoyita Roy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluation of Aminoglycoside and Non-Aminoglycoside Compounds for Stop-Codon Readthrough Therapy in Four Lysosomal Storage Diseases
- (2015) Marta Gómez-Grau et al. PLoS One
- Therapeutics Based on Stop Codon Readthrough
- (2014) Kim M. Keeling et al. Annual Review of Genomics and Human Genetics
- New insights into the incorporation of natural suppressor tRNAs at stop codons in Saccharomyces cerevisiae
- (2014) Sandra Blanchet et al. NUCLEIC ACIDS RESEARCH
- Functional Characterisation of Alpha-Galactosidase A Mutations as a Basis for a New Classification System in Fabry Disease
- (2013) Jan Lukas et al. PLoS Genetics
- α-Galactosidase Aggregation Is a Determinant of Pharmacological Chaperone Efficacy on Fabry Disease Mutants
- (2012) Aleksandra Siekierska et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse
- (2011) Dan Wang et al. MOLECULAR GENETICS AND METABOLISM
- Plasma globotriaosylsphingosine: Diagnostic value and relation to clinical manifestations of Fabry disease
- (2010) S.M. Rombach et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Fabry disease
- (2010) Dominique P Germain Orphanet Journal of Rare Diseases
- Catalytic Mechanism of Human α-Galactosidase
- (2009) Abigail I. Guce et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sorting of lysosomal proteins
- (2008) Thomas Braulke et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Lysosomal disorders: From storage to cellular damage
- (2008) Andrea Ballabio et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- A meta-analysis of nonsense mutations causing human genetic disease
- (2008) Matthew Mort et al. HUMAN MUTATION
- Fabry's disease
- (2008) Yuri A Zarate et al. LANCET
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started